These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 9692699)

  • 41. Can optimal acid suppression prevent rebleeding in peptic ulcer patients with a non-bleeding visible vessel: a preliminary report of a randomized comparative study.
    Lin HJ; Lo WC; Perng CL; Wang K; Lee FY
    Hepatogastroenterology; 1997; 44(17):1495-9. PubMed ID: 9356879
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Gastro-oesophageal reflux disease in primary care: an international study of different treatment strategies with omeprazole. International GORD Study Group.
    Carlsson R; Dent J; Watts R; Riley S; Sheikh R; Hatlebakk J; Haug K; de Groot G; van Oudvorst A; Dalväg A; Junghard O; Wiklund I
    Eur J Gastroenterol Hepatol; 1998 Feb; 10(2):119-24. PubMed ID: 9581986
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Maintenance therapy for erosive esophagitis in children after healing by omeprazole: is it advisable?
    Boccia G; Manguso F; Miele E; Buonavolontà R; Staiano A
    Am J Gastroenterol; 2007 Jun; 102(6):1291-7. PubMed ID: 17319927
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Omeprazole versus ranitidine or ranitidine/metoclopramide in poorly responsive symptomatic gastroesophageal reflux disease.
    Richter JE; Sabesin SM; Kogut DG; Kerr RM; Wruble LD; Collen MJ
    Am J Gastroenterol; 1996 Sep; 91(9):1766-72. PubMed ID: 8792695
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Partial symptom-response to proton pump inhibitors in patients with non-erosive reflux disease or reflux oesophagitis - a post hoc analysis of 5796 patients.
    Bytzer P; van Zanten SV; Mattsson H; Wernersson B
    Aliment Pharmacol Ther; 2012 Oct; 36(7):635-43. PubMed ID: 22860764
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Ranitidine versus cimetidine in the healing of erosive esophagitis.
    McCarty-Dawson D; Sue SO; Morrill B; Murdock RH
    Clin Ther; 1996; 18(6):1150-60. PubMed ID: 9001831
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Maintenance treatment for gastro-oesophageal reflux disease. A placebo-controlled evaluation of 10 milligrams omeprazole once daily in general practice.
    Venables TL; Newland RD; Patel AC; Hole J; Copeman MB; Turbitt ML
    Scand J Gastroenterol; 1997 Jul; 32(7):627-32. PubMed ID: 9246699
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Comparison of efficacy of pantoprazole alone versus pantoprazole plus mosapride in therapy of gastroesophageal reflux disease: a randomized trial.
    Madan K; Ahuja V; Kashyap PC; Sharma MP
    Dis Esophagus; 2004; 17(4):274-8. PubMed ID: 15569362
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Maintenance therapy of gastroesophageal reflux disease patients with omeprazole.
    Tepes B; Stabuc B; Kocijancic B; Ivanusa M
    Hepatogastroenterology; 2009; 56(89):67-74. PubMed ID: 19453031
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Standard-dose lansoprazole is more effective than high-dose ranitidine in achieving endoscopic healing and symptom relief in patients with moderately severe reflux oesophagitis. The Dutch Lansoprazole Study Group.
    Jansen JB; Van Oene JC
    Aliment Pharmacol Ther; 1999 Dec; 13(12):1611-20. PubMed ID: 10594396
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Symptomatic gastro-oesophageal reflux disease: double blind controlled study of intermittent treatment with omeprazole or ranitidine. The European Study Group.
    Bardhan KD; Müller-Lissner S; Bigard MA; Bianchi Porro G; Ponce J; Hosie J; Scott M; Weir DG; Gillon KR; Peacock RA; Fulton C
    BMJ; 1999 Feb; 318(7182):502-7. PubMed ID: 10024259
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Long-term management of gastroesophageal reflux disease and its complications.
    Richter JE
    Am J Gastroenterol; 1997 Apr; 92(4 Suppl):30S-34S; discussion 34S-35S. PubMed ID: 9127624
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Omeprazole in infants with cimetidine-resistant peptic esophagitis.
    Alliët P; Raes M; Bruneel E; Gillis P
    J Pediatr; 1998 Feb; 132(2):352-4. PubMed ID: 9506656
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A practical approach to heartburn.
    Castell DO
    Hosp Pract (1995); 1999 Nov; 34(12):89-94, 97-8. PubMed ID: 10616547
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Complete resolution of heartburn symptoms and health-related quality of life in patients with gastro-oesophageal reflux disease.
    Revicki DA; Crawley JA; Zodet MW; Levine DS; Joelsson BO
    Aliment Pharmacol Ther; 1999 Dec; 13(12):1621-30. PubMed ID: 10594397
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Erosive oesophagitis: outcome of repeated long term maintenance treatment with low dose omeprazole 10 mg or placebo.
    Bardhan KD; Cherian P; Vaishnavi A; Jones RB; Thompson M; Morris P; Brooks A; D'Silva J; Gillon KR; Wason C; Patterson J; Polak J; Bishop A
    Gut; 1998 Oct; 43(4):458-64. PubMed ID: 9824569
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Combination drug therapy for gastroesophageal reflux disease.
    Cross LB; Justice LN
    Ann Pharmacother; 2002 May; 36(5):912-6. PubMed ID: 11978171
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Review article: the role of acid suppression in patients with non-erosive reflux disease or functional heartburn.
    DeVault KR
    Aliment Pharmacol Ther; 2006 Mar; 23 Suppl 1():33-9. PubMed ID: 16483268
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Helicobacter pylori and the efficacy of omeprazole therapy for gastroesophageal reflux disease.
    Schenk BE; Kuipers EJ; Klinkenberg-Knol EC; Eskes SA; Meuwissen SG
    Am J Gastroenterol; 1999 Apr; 94(4):884-7. PubMed ID: 10201451
    [TBL] [Abstract][Full Text] [Related]  

  • 60. On-demand treatment of gastro-oesophageal reflux symptoms: a comparison of ranitidine 75 mg with cimetidine 200 mg or placebo.
    Galmiche JP; Shi G; Simon B; Casset-Semanza F; Slama A
    Aliment Pharmacol Ther; 1998 Sep; 12(9):909-17. PubMed ID: 9768535
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.